Top

Published in:

01-07-2012 | Case Report

Serious menstrual bleeding associated with use of TNF alpha blocker: two cases

Authors: Cemal Bes, Mehmet Soy

Published in: Rheumatology International | Issue 7/2012

Abstract

Menstrual disorders associated with the use of TNF alpha blocker have been rarely reported. Herein, we reported two cases aged 31 and 41, presenting with excessive menstrual bleeding occured after adalimumab administration which was subsequently discontinued.

Heijde D, Schiff MH, Sieper J, Kivitz A, Wong RL, Kupper H et al (2009) Adalimumab effectiveness fort he treatment of ankylosing spondylitis is maintained for up to 2 years: long term results from the ATLAS trial. Ann Rheum Dis 68:922–929PubMedCrossRef

Scheinfeld N (2008) Menorrhagia and severe menstruel pain related to the use of adalimumab in a psoriatic. J Dermatolog Treat 19(3):188–189PubMedCrossRef

Machold KP, Smolen JS (2003) Adalimumab-a new TNF-alpha antibody for treatment of inflammatory joint disease. Expert Opin Biol Ther 3:351–360PubMed

Valesini G, Iannuccelli C, Marocchi E, Pascoli L, Scalzi V, Di franco M (2007) Biological and clinical effects of anti-TNF alpha treatment. Autoimmun Rev 7(1):35–41PubMedCrossRef

Scheinfeld N (2004) Adalimumab (Humira): a brief review for dermatologists. J Dermatolog Treat 15(6):348–352PubMedCrossRef

http://www.fda.gov/cder/foi/label/2002/adalabb12310-2LB.pdf

Kayisli UA, Mahutte NG, Arici A (2002) Uterine chemokines in reproductive physiology and pathology. Am J Reprod Immunol 47(4):213–221PubMedCrossRef

Malik S, Day K, Perrault I, Charnock-Jones DS, Smith SK (2006) Reduced levels of VEGF-A and MMP-2 and MMP-9 activity and increased TNF-alpha in menstrual endometrium and effluent in women with menorrhagia. Hum Reprod 21(8):2158–2166PubMedCrossRef

Title: Serious menstrual bleeding associated with use of TNF alpha blocker: two cases
Authors: Cemal Bes
Mehmet Soy
Publication date: 01-07-2012
Publisher: Springer-Verlag
Published in: Rheumatology International / Issue 7/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-010-1455-9

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Serious menstrual bleeding associated with use of TNF alpha blocker: two cases

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 7/2012

Serum concentrations of antiphospholipid and anticardiolipin antibodies are higher in HIV-infected women

Behcet’s disease and IgA nephropathy

DRESS syndrome with fatal results induced by sodium valproate in a patient with brucellosis and a positive cytoplasmic antineutrophilic cytoplasmic antibody test result

Mycophenolate mofetil treatment in two children with severe polyarteritis nodosa refractory to immunosuppressant drugs

Balneotherapy in fibromyalgia: a single blind randomized controlled clinical study

Association of Fcγ receptor IIIA variant with a subset of anti-topoisomerase I-positive patients in systemic sclerosis: a descriptive pilot study

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page